Influenza A virus vaccine H1N1 - Adimmune CorporationAlternative Names: Adimflu-S; Adimflu-S Children; Seasonal influenza virus vaccine - Adimmune
Latest Information Update: 14 Feb 2014
At a glance
- Originator Adimmune Corporation
- Class Influenza A virus H1N1 vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza A virus H1N1 subtype
Most Recent Events
- 31 Dec 2010 Launched for Influenza A virus H1N1 subtype (prevention) in Taiwan (SC)
- 31 Dec 2010 Launched for Influenza A virus H1N1 subtype (prevention) in Taiwan (IM)